How novel anticoagulants compare with warfarin for intraocular bleeding

Article

How do the newer anticoagulant medications compare with warfarin when it comes to the risk of intraocular bleeding? A meta-analysis published in JAMA Ophthalmology did a systematic review of phase 3 randomized trials looking at over 100,000 patients.

How do the newer anticoagulant medications compare with warfarin when it comes to the risk of intraocular bleeding? 

A meta-analysis published in JAMA Ophthalmology did a systematic review of phase 3 randomized trials looking at over 100,000 patients.

The results indicated the risk of intraocular bleeding was reduced by one-fifth with newer anticoagulants, compared with warfarin. This was especially relevant for patients with a higher risk of spontaneous retinal and subretinal hemorrhage. 

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
© 2024 MJH Life Sciences

All rights reserved.